Surgical management of heart failure: An overview

Annual Review of Medicine

Volumn 53, Issue , 2002, Pages 383-391

  Zeltsman, David ^a   Acker, Michael A ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Dor procedure; Mechanical circulatory support; Mitral valve repair; Transplantation

Indexed keywords

ARTIFICIAL HEART; ASSISTED CIRCULATION; CLINICAL FEATURE; DEVICE; HEART FAILURE; HEART MUSCLE REVASCULARIZATION; HEART TRANSPLANTATION; HEART VENTRICLE REMODELING; HEMODYNAMICS; HUMAN; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ANIMALS; CARDIOMYOPLASTY; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HEART VENTRICLES; HUMANS; MITRAL VALVE; MYOCARDIAL REVASCULARIZATION; SURVIVAL ANALYSIS;

EID: 0036190673     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.53.082901.104101     Document Type: Review

References (54)

1. Structural basis for heart failure
2. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial
3. Effects of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure
4. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction
5. A randomized trial of beta-blockade in heart failure: The Cardiac Insufficiency Bisoprolol Study (CIBIS)
6. The Cardiac Insufficiency Bisoprolol Study (CIBIS II): A randomized trial
7. Effects of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomized trial in congestive heart failure
8. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
9. Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure
10. Regional wall stress predicts ventricular remodeling after anteroseptal myocardial infarction in the Healing and Early After-load Reducing Trial (HEART): An echocardiography-based structural analysis
11. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction
12. Randomized, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischemic heart disease
13. Worldwide thoracic organ transplantation: A report from the UNOS/ISHET International Registry for Thoracic Organ Transplantation
14. Myocardial revascularization for the treatment of post-ischemic heart failure
15. Coronary artery bypass grafting in patients with advanced left ventricular dysfunction
16. Myocardial viability assessment in ischemic cardiomyopathy: Benefits of coronary revascularization
17. The bad ventricle - Revascularization versus transplantation
18. Coronary bypass with ejection fraction of 0.20 or less using centigrade cardioplegia: Long-term follow-up
19. Coronary artery bypass grafting in patients with an ejection fraction of twenty percent or less
20. Mitral valve repair for ischemic mitral insufficiency
21. Intermediate-term outcome of mitral reconstruction in cardiomyopathy
22. Mitral valve repair in heart failure
23. Preservation of normal left ventricular geometry during mitral valve replacement
24. Restoration of left ventricular systolic performance after reattachment of the mitral chordae tendineae. The importance of valvular-ventricular interaction
25. Importance of preserving the mitral subvalvular apparatus in mitral valve replacement
26. Late hemodynamic effects of the preserved papillary muscles during mitral valve replacement
27. Partial left ventriculectomy to improve left ventricular function in end-stage heart disease
28. Partial left ventriculectomy to treat end-stage heart disease
29. Partial left ventriculectomy and mitral valve repair for end-stage congestive heart failure
30. Results after partial left ventriculectomy versus heart transplantation for idiopathic cardiomyopathy
31. Left ventricular aneurysm: A new surgical approach
32. Surgical anterior ventricular endocardial restoration (SAVER) in the dilated remodeled ventricle after anterior myocardial infarction. RESTORE group. Reconstructive endoventricular surgery, returning torsion original radius elliptical shape to the LV
33. Efficacy of endoventricular patch plasty in large postinfarction akinetic scar and severe left ventricular dysfunction: Comparison with a series of large dyskinetic scars
34. Effects of the Dor procedure on left ventricular dimension and shape and geometric correlates of mitral regurgitation one year after surgery
35. Chronic therapy with the Acorn Cardiac Support Device in dogs with chronic heart failure: Three and six months hemodynamic, histologic and ultrastructural findings
36. Prevention of progressive left ventricular dilation with the Acorn Cardiac Support Device down regulates stretch-response proteins and improves sarcoplasmic reticulum recycling in dogs with chronic heart failure
37. Reverse remodeling and enhanced adrenergic reserve from a passive external ventricular support in experimental dilated heart failure
38. Prevention of progressive left ventricular dilation with the Acorn Cardiac Support Device (CSD) down regulates stretch-mediated p21ras, attentuates myocyte hypertrophy and improves sarcoplasmic reticulum calcium cycling in dogs with heart failure
39. Passive epicardial containment prevents ventricular remodeling in heart failure
40. Chronic therapy with the Acorn Cardiac Support Device (CSD) attentuates cardiomyocyte apoptosis in dogs with heart failure
41. Follow-up on passive cardiomyoplasty in congestive heart failure: Influence on the Acorn Cardiac Support Device on left ventricular function
42. Mechanical support for postcardiotomy cardiogenic shock
43. Clinical experience with the Novacor ventricular assist system. Bridge to transplantation and the transition to permanent application
44. Potential of left ventricular assist devices as outpatient therapy while awaiting transplantation
45. 100 Long-term implantable left ventricular assist devices: The Columbia Presbyterian interim experience
46. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy
47. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure
48. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis
49. Mechanical circulatory support for patients with acute/fulminant myocarditis
50. The REMATCH trial: Rationale, design, and end points. Randomized evaluation of mechanical assistance for the treatment of congestive heart failure
51. Left ventricular assist devices and the failing heart: A bridge to recovery, a permanent assist device, or a bridge too far?
52. Future directions of cardiac assistance